ArticleBiology direct2026
Obesity-associated lysosomal nitrosative stress promotes retinopathy.
Article in Biology direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundObesity and diabetes are major risk factors causing vision loss around the world, yet the molecular mechanisms linking obesity to retinal pathology remain incompletely understood. While chronic inflammation and dysregulated vascular endothelial growth factor (VEGF) signaling are established contributors to retinopathy, their integration within the context of obesity has not been fully elucidated.
methodsRetinal transcriptomic RNA sequencing datasets from patients with type 2 diabetes mellitus (T2DM) and obese mouse models were retrieved from the GEO database. Meta-analysis was performed using MetaVolcanoR to identify differentially expressed genes associated with obesity- and diabetes-related retinal alterations. The functional impact of cathepsin B (CTSB) S-nitrosylation on retinal VEGF expression was investigated in diet-induced obese wild-type and transgenic mouse models through molecular and biochemical approaches, including biotin switch assay, ELISA, and quantitative RT-PCR, etc.
resultsWe conducted a meta-analysis of retinal transcriptomic datasets from T2DM patients and obese mouse models and found that obesity promotes retinal inflammation and vascular endothelial cell proliferation and migration signatures. These transcriptomic profiles were further confirmed by biochemical analysis and gene expression analysis in mice with diet-induced obesity. Moreover, we demonstrated that obesity increased retinal inducible nitric oxide synthase (iNOS) expression but suppressed S-nitrosoglutathione reductase (GSNOR) activity, two essential regulators for nitrosative stress. At the cellular level, we showed that obesity promoted retinal lysosomal nitrosative stress, leading to impaired retinal CTSB activity, a critical lysosomal enzyme. Of note, in the context of obesity, the nitrosative stress-promoted lysosomal impairment is correlated with an accumulation of retinal VEGF. Functionally, suppression of nitrosative stress by iNOS deletion reduced retinal VEGF expression and restored retinal lysosomal function in obese mice. In contrast, elevation of nitrosative stress by GSNOR deletion in obese mice worsened the retinal lysosomal nitrosative stress and lysosomal enzymatic defects.
conclusionOur findings identify lysosomal nitrosative stress as a pivotal mediator that links obesity-driven inflammation to impaired VEGF homeostasis in the retina, thereby advancing our understanding of the molecular underpinnings of obesity-associated retinopathy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.